| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $517.6M | +28.2% |
| Gross Profit | $318.2M | +22.9% |
| R&D Expense | $1.1M | +266.7% |
| SG&A Expense | $259.0M | +62.4% |
| Operating Income | $364K | -99.5% |
| Pre-tax Income | -$6.6M | -111.3% |
| Income Tax | $1.0M | -50.6% |
| Net Income | -$4.9M | -146.3% |
| EPS (Basic) | -$0.08 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.3M | -7.2% |
| Accounts Receivable | $26.2M | +21.7% |
| Inventory | $133.0M | +30.0% |
| Current Assets | $195.1M | +22.8% |
| Total Assets | $862.3M | +2.9% |
| Current Liabilities | $67.0M | +43.9% |
| Long-term Debt | $113.4M | -11.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $32.4M | +416.2% |
| Capital Expenditures | $9.2M | -13.2% |
| Investing Cash Flow | -$10.0M | +93.0% |
| Financing Cash Flow | -$23.5M | -116.1% |
| Free Cash Flow | $23.2M | +210.8% |
| -147.1% |
| EPS (Diluted) | -$0.08 | -147.1% |
| Stockholders' Equity |
| $363.4M |
| +0.7% |